Buchholz Richard
Buchholz Richard's purchase track record
Buchholz Richard has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/13/2026 | SI | $15K | +26.2% | +25.0% | +15.4% |
| 8/1/2025 | SI | $75K | -17.8% | -0.6% | +11.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Barclays Starts Coverage of Inspire Medical with Underweight. Barclays has begun coverage of Inspire Medical Systems and assigned an Underweight rating. The firm set a price target of $65 for the stock. This rating follows the recent analyst activity on the company. The stock is currently near its long‑term support level.
Transaction History
| SI | ▲ Buy | Grant | 5,046 | $0 | 6/26/2026 | View on chart |
| SI | ▲ Buy | Open Market | 1,000 | $15K | 3/13/2026 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 579 | $35K | 2/13/2026 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 327 | $22K | 2/9/2026 | View on chart |
| INSP | ▼ Sell | Open Market | 11,000 | $1.0M | 8/29/2025 | View on chart |
| INSP | ▲ Buy | Option Exercise | 17,849 | $1.3M | 8/19/2025 | View on chart |
| INSP | ▲ Buy | Option Exercise | 7,159 | $302K | 8/19/2025 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 2,649 | $239K | 8/19/2025 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 2,455 | $221K | 8/19/2025 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 276 | $25K | 8/19/2025 | View on chart |
| SI | ▲ Buy | Grant | 7,666 | $0 | 8/1/2025 | View on chart |
| SI | ▲ Buy | Open Market | 5,000 | $75K | 8/1/2025 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 2,200 | $410K | 2/24/2025 | View on chart |
| INSP | ▲ Buy | Grant | 6,152 | $0 | 2/24/2025 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/21/2025 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/21/2025 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/21/2025 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/21/2025 | View on chart |
| INSP | ▼ Sell | Gift | 500 | $0 | 2/21/2025 | View on chart |
| INSP | ▲ Buy | Grant | 5,076 | $0 | 2/13/2025 | View on chart |
| INSP | ▼ Sell | Tax Withholding | 314 | $57K | 2/9/2025 | View on chart |
| INSP | ▼ Sell | Open Market | 15,000 | $3.5M | 4/17/2024 | View on chart |
| INSP | ▼ Sell | Gift | 500 | $0 | 4/17/2024 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 4/17/2024 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 4/17/2024 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 4/17/2024 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 4/17/2024 | View on chart |
| INSP | ▲ Buy | Grant | 2,694 | $0 | 2/9/2024 | View on chart |
| INSP | ▲ Buy | Option Exercise | 3,290 | $34K | 1/25/2023 | View on chart |
| INSP | ▲ Buy | Option Exercise | 117 | $8K | 1/25/2023 | View on chart |
| INSP | ▲ Buy | Option Exercise | 2,693 | $114K | 1/25/2023 | View on chart |
| INSP | ▼ Sell | Open Market | 11,977 | $3.0M | 1/13/2023 | View on chart |
| INSP | ▼ Sell | Open Market | 523 | $131K | 1/11/2023 | View on chart |
| INSP | ▼ Sell | Gift | 400 | $0 | 1/5/2023 | View on chart |
| INSP | ▼ Sell | Gift | 100 | $0 | 1/5/2023 | View on chart |
| INSP | ▼ Sell | Gift | 100 | $0 | 1/5/2023 | View on chart |
| INSP | ▼ Sell | Gift | 100 | $0 | 1/5/2023 | View on chart |
| INSP | ▼ Sell | Gift | 100 | $0 | 1/5/2023 | View on chart |
| INSP | ▼ Sell | Open Market | 5,500 | $1.4M | 4/1/2022 | View on chart |
| INSP | ▼ Sell | Open Market | 5,362 | $1.4M | 4/1/2022 | View on chart |
| INSP | ▼ Sell | Open Market | 4,037 | $1.0M | 4/1/2022 | View on chart |
| INSP | ▼ Sell | Open Market | 101 | $26K | 4/1/2022 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/18/2022 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/18/2022 | View on chart |
| INSP | ▼ Sell | Gift | 250 | $0 | 2/18/2022 | View on chart |
| INSP | ▼ Sell | Gift | 250 | $0 | 2/17/2022 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/17/2022 | View on chart |
| INSP | ▼ Sell | Gift | 125 | $0 | 2/17/2022 | View on chart |
| INSP | ▲ Buy | Option Exercise | 2,819 | $29K | 9/28/2021 | View on chart |
| INSP | ▲ Buy | Option Exercise | 329 | $309 | 9/28/2021 | View on chart |
| INSP | ▲ Buy | Option Exercise | 1,607 | $68K | 9/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Shoulder Innovations Q2 2026 earnings and BTIG target raise
Shoulder Innovations held its Q2 2026 earnings conference call, where management discussed the quarter’s results. BTIG analyst kept its rating on the stock and increased the price target to $27. The new target is above the current average analyst estimate of $26.25 and above the 52‑week high of $24.59.
Shoulder Innovations Q2 2026 earnings and BTIG target raise. Shoulder Innovations held its Q2 2026 earnings conference call, where management discussed the quarter’s results. BTIG analyst kept its rating on the stock and increased the price target to $27. The new target is above the current average analyst estimate of $26.25 and above the 52‑week high of $24.59.